The IPO Buzz: Sagimet Biosciences (SGMT) Dips in its NASDAQ Debut
Liver disease and cancer biotech Sagimet Biosciences (SGMT) shares slipped 50 cents to open at $15.50 – down 3.13 percent from its $16.00 IPO price – in its opening trade at 12:29 p.m. EDT today – Friday, July 14, 2023 – on the NASDAQ. Volume was 314,948 shares, NASDAQ records showed. The stock recovered to trade […]
July 14, 2023 Read More